💨 Abstract

Novo Nordisk reported a second-quarter profit of $4.03 billion, exceeding analyst earnings expectations. The company earned 91 cents per share, with adjusted earnings of 97 cents per share. Revenue was $11.69 billion, slightly below forecasts. The drugmaker's performance beat Wall Street's earnings projections but missed on revenue.

Courtesy: WTOP Staff